Acta Biochimica et Biophysica Sinica · 2022 · 25 citations · 19 references
MedicineOncologyPharmacologyApoptosisAutophagyCancer PharmacologyAutophagy In CancerCancer ProgressionCell Cycle PharmacologyLiver CancerMalignant NeoplasmsCancer Cell ApoptosisCancer Cell Proliferation InhibitionCell Cycle Arrest MechanismsCell Cycle Arrest SignalingCell Cycle InhibitorsCell Cycle-targeted TherapeuticsEndoplasmic Reticulum FunctionSorafenib Therapy
<p indent="0mm">Primary hepatic carcinoma is a common malignant tumor. The classic molecular targeted drug sorafenib is costly and is only effective for some patients. Therefore, it is of great clinical significance to search for new molecular targeted drugs. Eupalinolide B (EB) from <italic>Eupatorium lindleyanum</italic> DC. is used to treat chronic tracheitis in clinical practice. However, the role of EB in hepatic carcinoma is unknown. In this study, we first measure the effect of EB on tumor growth in a xenograft model and PDX model. The cell proliferation and migration are also detected in human hepatocarcinoma cell lines (SMMC-7721 and HCCLM3). Then, we investigate cell cycle, cell apoptosis, cell necrosis, cell autophagy, and ferroptosis by flow cytometry, western blot analysis and electron microscopy. The results demonstrate that EB exerts anti-proliferative activity in hepatic carcinoma by blocking cell cycle arrest at S phase and inducing ferroptosis mediated by endoplasmic reticulum (ER) stress, as well as HO-1 activation. When HO-1 is inhibited, EB-induced cell death and ER protein expression are rescued. The migration-related mechanism consists of activation of the ROS-ER-JNK signaling pathway and is not connected to ferroptosis. In summary, we first discover that EB inhibits cell proliferation and migration in hepatic carcinoma, and thus EB is a promising anti-tumor compound that can be used for hepatic carcinoma.
19
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon, Kathryn M. Lemberg, Michael R. Lamprecht et al. · Cell · 2012 · 18.1K citations · Full text
Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs et al. · CA A Cancer Journal for Clinicians · 2021 · 17.4K citations · Full text
Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death
Min‐Young Kwon, Eun‐Hee Park, Seon‐Jin Lee et al. · Oncotarget · 2015 · 614 citations · Full text
Heme oxygenase-1 mediates BAY 11–7085 induced ferroptosis
Ling‐Chu Chang, Shih-Kai Chiang, Shuen‐Ei Chen et al. · Cancer Letters · 2017 · 563 citations